Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 100,000 | reported | 10 Nov 2025 | tx 1+100,000 |
| DEXCOM INC | 66,641 | reported | 12 Mar 2024 | tx 3+71,405−4,764 |
| Altimmune, Inc. | 48,800 | reported | 25 Sept 2025 | tx 2+118,600 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Nov 2025 | GRANT_AWARD | Celldex Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 25 Sept 2025 | GRANT_AWARD | Altimmune, Inc. | 48,800 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Altimmune, Inc. | 69,800 | 0.00 USD | deriv |
| 12 Mar 2024 | SALE | DEXCOM INC | 4,764 | 134.41 USD | |
| 08 Mar 2024 | GRANT_AWARD | DEXCOM INC | 26,053 | 0.00 USD | |
| 08 Mar 2023 | GRANT_AWARD | DEXCOM INC | 45,352 | 0.00 USD |